Auna SA AUNA

Health CareHealthcare Providers & ServicesLuxembourg

Last close 4.50 USD on Nov 2, 2026, −8.5% year to date

Quant rating

Quant rating C Rank 114 of 211 in Health Care

Growth D 187 of 211
Valuation A 27 of 211
Quality B 42 of 211
Revisions C 123 of 211
Momentum D 178 of 211

Wall Street consensus Buy (1.88)Average target 7.83 USD +74.0%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 333M
Enterprise value: 1.3B
52-week range: 4.09 – 6.29
3-year range: 4.09 – 10.66
Dividend yield: –
Beta (5 years): –
Shares outstanding: 74.0M
Next earnings: Nov 17, 2026

About the company

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	1,304	1,168	1,046	645	483	–
Revenue growth	11.6%	11.7%	62.3%	33.5%	21.0%	26.7%
EPS (basic, normalized)	1.28	0.54	–	–	–	–
EPS growth	137.5%	–	–	–	–	–
Gross margin	38.0%	39.3%	37.1%	36.1%	35.7%	37.2%
Net margin	2.2%	2.5%	−6.6%	−3.5%	−1.4%	−1.3%
ROE	6.3%	7.5%	−20.1%	−11.0%	−4.8%	−4.4%

Balance sheet, last quarter
Cash & short-term investments (mil)	141
Current ratio	1.08x
Long-term debt (mil)	966
Net debt (mil)	1,007
Total equity (mil)	544
Net debt / equity	1.85x
Net debt / EBITDA	3.76x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	1,304	+11.6%	1.0x	268	−0.3%	4.9x	1.28	+137.5%	3.5x
2026	1,417	+8.7%	0.9x	280	+4.4%	4.7x	0.91	−28.7%	5.0x
2027	1,494	+5.4%	0.9x	307	+9.7%	4.3x	1.15	+26.7%	3.9x
2028	1,610	+7.8%	0.8x	333	+8.6%	4.0x	1.33	+15.2%	3.4x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	1,417	0.0%	+1.8%	+4.0%	0.91	0.0%	−10.2%	+0.6%
2027	1,494	0.0%	+1.7%	+3.1%	1.15	0.0%	−6.8%	+3.8%
2028	1,610	0.0%	+5.4%	+6.9%	1.33	0.0%	−10.1%	+1.4%

Earnings surprises EPS beat in 1 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	FQ-1	FQ0
Sales reported (mil)	1,076	1,120	1,127	1,063	1,042	1,094	1,117	1,133	1,178	1,238
Sales mean (mil)	1,048	1,075	1,179	1,100	1,134	1,114	1,136	1,109	1,130	1,191
Surprise	+2.7%	+4.2%	−4.4%	−3.4%	−8.1%	−1.8%	−1.7%	+2.1%	+4.2%	+4.0%
EPS reported	0.36	0.12	0.98	0.47	0.70	1.17	0.71	1.78	–	–
EPS mean	0.49	0.57	0.70	0.51	0.48	0.55	0.82	0.72	–	–
Surprise	−26.5%	−79.1%	+39.1%	−8.4%	+46.8%	+114.7%	−13.7%	+145.5%	–	–

Peer comparison Healthcare Providers & Services

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
AUNA Auna SA	333M	3.76x	2.2%	0.62x	5.0x	3.9x	4.7x	4.3x
RDOR3 Rede D'Or Sao Luiz SA	13.1B	1.17x	8.4%	3.33x	14.3x	11.7x	6.9x	6.1x
FLRY3 Fleury S.A.	2.1B	1.74x	7.4%	2.05x	13.7x	11.7x	6.2x	5.7x
ENSG The Ensign Group, Inc.	10.4B	−0.31x	6.8%	4.08x	22.6x	20.6x	13.8x	12.5x
CON Concentra Group Holdings Parent Inc	5.1B	3.35x	7.6%	10.78x	24.5x	21.9x	13.3x	12.4x
NHC National Healthcare Corp	3.2B	–	7.9%	2.82x	–	–	–	–
Mean		1.94x	6.7%	3.95x	16.0x	13.9x	9.0x	8.2x
Median		1.74x	7.5%	3.08x	14.3x	11.7x	6.9x	6.1x

Technical analysis

1M−11.1%
3M−11.2%
1Y−23.9%
3Y−53.1%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Auna SA, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	1,304	1,168	1,046	645	483	399
Cost of revenue	809	709	658	412	310	253
Gross profit	495	460	388	233	172	146
Selling, general & administrative expenses	289	247	217	158	142	112
Research & development	–	–	–	–	–	–
Depreciation/amortization	32.8	26.7	26.7	11.4	5.1	4.7
Interest expense (income), operating	0	0	0	0	0	0
Unusual expense (income)	18.2	1.7	15.9	1.1	0	−1.8
Other operating expenses	−11.5	−22.9	−6.5	−5.2	−1.9	−1.3
Operating income	167	207	134	66.9	27.1	32.7
Net interest income (expense)	−95.3	−145	−144	−75.7	−26.8	−35.0
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	−12.1	−13.0	−24.3	−3.7	−1.1	−1.4
Net income before taxes	59.3	49.0	−33.5	−12.5	−0.8	−3.7
Provision for taxes	26.3	15.9	24.3	7.7	5.0	−2.2
Minority interest	−4.0	−3.6	−10.7	−2.3	−0.9	−0.5
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	29.0	29.4	−68.6	−22.5	−6.6	−2.0
Extraordinary items	–	–	–	–	–	–
Net income	29.0	29.4	−68.6	−22.5	−6.6	−2.0
EBIT, normalized	185	209	150	68.0	27.1	30.9
EBITDA, normalized	251	267	214	104	46.5	48.8
Basic EPS, normalized	1.28	0.54	–	–	–	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Auna SA, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	109	89.5	90.2	54.9	34.8	94.9
Receivables	310	256	232	151	88.5	102
Total inventory	49.0	38.3	35.2	23.0	15.3	14.5
Prepaid expenses	–	–	–	–	–	–
Other current assets	80.7	69.9	60.3	85.4	29.8	19.2
Total current assets	549	454	418	314	168	231
Property, plant & equipment	716	644	734	650	339	333
Goodwill	536	467	559	475	46.4	54.6
Intangibles	268	240	286	251	81.6	81.0
Long-term investments	9.1	6.8	5.6	3.4	3.6	3.3
Note receivable	0.1	0.2	0.1	0.1	0.1	0.1
Other long-term assets	92.7	73.6	73.0	40.9	69.0	29.4
Total assets	2,170	1,886	2,076	1,734	709	733
Liabilities
Accounts payable	308	247	221	131	111	93.8
Payable/accrued	0.4	0.3	0.3	0.5	0.6	3.9
Accrued expenses	26.8	29.8	33.4	17.3	15.6	15.8
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	103	183	113	544	11.7	10.2
Other current liabilities	57.8	58.1	89.1	55.2	36.0	32.9
Total current liabilities	496	518	456	748	175	157
Long-term debt	984	821	946	379	363	364
Minority interest	49.2	38.8	84.0	130	12.6	14.1
Other liabilities	165	115	195	197	33.3	31.6
Total liabilities	1,694	1,493	1,680	1,454	584	566
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	5.2	4.6	2.4	62.2	59.4	65.4
Additional paid-in capital	360	322	0	102	96.9	107
Retained earnings (accumulated deficit)	162	135	362	175	−18.6	−13.1
Treasury stock	–	–	–	–	–	–
Other equity	−50.5	−67.6	31.6	−58.4	−13.2	7.2
Total equity	476	394	396	280	124	166
Total liabilities & shareholders' equity	2,170	1,886	2,076	1,734	709	733

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Auna SA, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	33.0	33.0	−57.9	−20.2	−5.8	−1.5
Depreciation, depletion & amortization	66.1	58.4	63.6	36.3	19.4	17.9
Deferred taxes	–	–	–	–	–	–
Non-cash items	171	179	216	88.6	42.1	38.4
Changes in working capital	−73.2	−92.4	−64.7	−61.9	−9.7	−11.6
Cash from operations	197	178	157	42.8	46.0	43.2
Investing activities
Capital expenditures	−43.0	−37.8	−44.6	−40.0	−72.6	−35.6
Other investing cash flows	19.2	−25.3	−2.2	−804	−0.7	0.8
Cash from investing	−23.9	−63.1	−46.7	−844	−73.3	−34.8
Financing activities
Financing cash flow items	−135	−463	−183	320	−26.4	−12.9
Cash dividends paid	–	–	–	–	–	–
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−9.9	351	83.2	503	0.8	88.3
Cash from financing	−145	−111	−99.9	823	−25.6	75.4
Foreign exchange effects	1.4	−5.0	−1.8	−3.7	1.5	1.2
Net change in cash	29.6	−1.4	8.8	18.4	−51.4	84.9
Free cash flow	154	140	113	2.8	−26.6	7.6

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.